US 11919901
Inhibitors of the menin-MLL interaction
granted A61KA61K31/506A61K31/53
Quick answer
US patent 11919901 (Inhibitors of the menin-MLL interaction) held by Syndax Pharmaceuticals, Inc. expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Syndax Pharmaceuticals, Inc.
- Grant date
- Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/506, A61K31/53, A61K31/5377, A61P